Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
about
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesLuciferase fragment complementation imaging in preclinical cancer studiesMicrofluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxisInhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaChemokine receptor oligomerization and allostery.C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.Chemokine signaling in development and disease.Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Mathematical Model of the Firefly Luciferase Complementation Assay Reveals a Non-Linear Relationship between the Detected Luminescence and the Affinity of the Protein Pair Being AnalyzedTouch of chemokines.Concise review: the potential of stromal cell-derived factor 1 and its receptors to promote stem cell functions in spinal cord repair.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis.The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.The differences in CXCR4 protein expression are significant for the five molecular subtypes of breast cancer.The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites.Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.CXCR7 Targeting and Its Major Disease Relevance.
P2860
Q26782778-9BA3A76B-0ECC-41B7-95C0-5527F720032CQ26851635-D0688E48-A2B5-4AAF-8B04-25C563A1189CQ33668704-D3CE6DB3-CB47-4533-985D-814838886D01Q33775283-F2850531-8E90-4605-8F34-BE425670355AQ33810517-EBC83237-882C-4AF5-BF8A-C8CB3A6CDD27Q33827026-BA7A9603-DC31-49DF-BF10-8ECB5C29F873Q33829364-D0DA50A8-439B-4243-9FE6-FDEB81FF00A7Q34231598-C88A1C2B-B24B-4B54-870C-D04B2C129492Q34999307-0E1B4455-B956-4D55-A420-580C2AFFE675Q35156945-ED3E1F04-5870-44A8-85A3-6B82901914E8Q35739397-9BCD38AB-21C0-479D-8AAE-0767414C4C86Q35926186-6693DF14-1BEA-4768-9C17-6990B1F3D63EQ36090029-F7924B69-B199-449E-9036-2F454EFF6F24Q38063844-84AAB283-0008-40F9-93A3-37B145F9BB61Q38223391-37B2D4A5-323E-43CB-B247-589757BEFB80Q38549839-C869C74B-1C65-490A-BC96-E849CB21F3C9Q42344029-F77ACF3B-4940-4BB5-A14A-1396431A23C6Q42517492-A5CE6732-8AA1-40D2-A720-B2A718F5E9DCQ51590709-D7009A23-98AF-427D-8B47-F6FAC733A5E2Q55370445-04BAD26A-266A-433D-9882-B70308CD4BE3Q55513575-1DB91A15-2E54-4FB7-AD80-5029E027B8CE
P2860
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@ast
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@en
type
label
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@ast
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@en
prefLabel
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@ast
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@en
P2093
P2860
P356
P1433
P1476
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
@en
P2093
Gary D Luker
Laura Anne Mihalko
Paramita Ray
Sarah A Lewin
Sasha-Cai Lesher-Perez
Shuichi Takayama
P2860
P304
P356
10.1042/BJ20111341
P407
P577
2012-03-01T00:00:00Z